Approval · Notice of Compliance 1936 · 1999
ASACOL: Notice of Compliance 1936
Issued February 16, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1936
- Date
- February 16, 1999
- Company
- Procter & Gamble Inc.Cincinnati, Ohio, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update
- Therapeutic class
- Lower gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASACOL | Not yet assigned | — |
Medicinal ingredients
- MESALAZINE 400 MG per TAB